Pilot Projects to Enhance the Human Virome Program (R03, Clinical Trials Not Allowed)

The Pilot Projects to Enhance the Human Virome Program (R03, Clinical Trials Not Allowed) is a forthcoming funding opportunity initiated by the National Institutes of Health (NIH), under the auspices of the U.S. Department of Health and Human Services. This program is part of the NIH Common Fund's Human Virome Program (HVP), a strategic initiative aimed at advancing our understanding of the complex array of viruses—collectively known as the virome—that inhabit the human body. These viruses may play significant roles in health and disease, yet remain poorly characterized. The HVP seeks to address this knowledge gap through comprehensive characterization, new methodological developments, and collaborative research efforts across the biomedical research community. The primary objective of this particular notice of funding opportunity (NOFO) is to support small-scale pilot research projects that extend, enhance, or complement ongoing work within the Human Virome Program. It specifically encourages the development and validation of new tools, models, and methods using existing or novel human specimens collected through HVP cohorts, or samples derived from animals. The overarching aim is to refine tools that enable more accurate assessment of virome composition and its interaction with host biological factors. Projects may also focus on expanding sampling sites or cohorts for more diverse virome representation, or on understanding the biological interactions between host and virome. Importantly, proposed efforts must not duplicate existing HVP-funded projects, and instead should explore novel or underexplored directions aligned with HVP goals. This opportunity is structured under the R03 funding mechanism, which supports discrete, well-defined research projects that can be completed within a limited timeframe and budget. The expected project duration is short and the funding scale modest, with award amounts ranging from $50,000 to $100,000. A total program budget of $2,000,000 is anticipated, with approximately 13 awards to be made. No cost-sharing or matching funds are required from applicants. The projects funded through this NOFO are expected to promote interdisciplinary collaboration and broaden the scope and utility of HVP resources and findings. Eligibility is broadly defined and inclusive, allowing a wide range of applicants to participate. Eligible entities include public and private institutions of higher education, state and local governments, tribal organizations (both federally recognized and not), nonprofits (with and without IRS 501(c)(3) status), small businesses, for-profit organizations, public housing authorities, and other governmental agencies. In addition, regional organizations, U.S. territories, and community or faith-based groups are eligible to apply, as are independent school districts and special district governments. This extensive eligibility list reflects NIH’s commitment to fostering widespread innovation and inclusive participation in federally funded health research. As of the forecast date, March 10, 2026, the opportunity is not yet accepting applications. The expected post date is September 8, 2026, with a projected application due date of November 10, 2026. Award notifications are anticipated by July 1, 2027, and funded projects would begin on or around August 1, 2027. There are no known pre-application requirements such as letters of intent or concept papers at this stage, and the program does not permit clinical trials. Applicants seeking more information are encouraged to contact the Human Virome Program team via email at [email protected]. As this is a forecasted opportunity, all deadlines and details are subject to change. Potential applicants should monitor Grants.gov and NIH notices for updates or the official release of the full funding announcement later in 2026.